20.00
price down icon3.01%   -0.62
 
loading

Pharvaris Nv (PHVS) 最新ニュース

pulisher
03:40 AM

Volatility clustering patterns for Pharvaris N.V.Trading Watchlist with Real Time Filters - Newser

03:40 AM
pulisher
03:38 AM

Combining machine learning predictions for Pharvaris N.V.AI Stock Movement Forecast with Accuracy - Newser

03:38 AM
pulisher
Jul 28, 2025

Why is Pharvaris N.V. stock attracting strong analyst attentionFinancial News Planner Backed By Experts - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How to integrate Pharvaris N.V. into portfolio analysis tools Short Term Opportunity Finder with Tools - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

How strong is Pharvaris N.V. company’s balance sheetUnlock your trading potential today - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is the dividend policy of Pharvaris N.V. stockConsistently exceptional gains - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What markets is UKOMW expanding into Is Pharvaris N.V. stock a good long term investment optionInvest confidently with real-time updates - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is Pharvaris N.V. a growth stock or a value stockCapitalize on emerging investment opportunities - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What is Pharvaris N.V. company’s growth strategyFree Advanced Stock Screener Access - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Pharvaris Announces US$201.2 Million Public Offering of Shares and Pre-Funded Warrants - Global Legal Chronicle

Jul 27, 2025
pulisher
Jul 27, 2025

Is Pharvaris N.V. a Top Dividend Stock to Watch in 2025Free Premium Stock Market Reports - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

New Product Launches: Will They Boost Pharvaris N.V. Stock in 2025High Probability Setups - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Pharvaris N.V.'s (NASDAQ:PHVS) 11% loss last week hit both individual investors who own 37% as well as institutions - Yahoo.co

Jul 27, 2025
pulisher
Jul 27, 2025

Pharvaris N.V. Stock Performance After Earnings: Historical InsightsFree Access to Community - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

How Interest Rate Changes Impact Pharvaris N.V. Stock PerformanceElite Investor Club - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

How Resilient Is Pharvaris N.V. Stock During Economic DownturnsHigh Return Potential - Newser

Jul 27, 2025
pulisher
Jul 26, 2025

What makes Pharvaris N.V. stock price move sharplyPro Trader Stock Focus - metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

What analysts say about Pharvaris N.V. stockRecord-setting profit potential - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Pharvaris' $201.2M Funding: A Strategic Catalyst for HAE Treatment Innovation and Shareholder Value - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

Pharvaris N.V. Stock Analysis and ForecastDynamic investment opportunities - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

How Pharvaris N.V. stock performs during market volatilityFree Short-Term Stock Picks - Newser

Jul 25, 2025
pulisher
Jul 25, 2025

How Pharvaris N.V. stock reacts to Fed policy changesRapidly growing investment returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Pharvaris Raises $201 Million in Successful Offering - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

Pharvaris Announces Closing of $201.2 Million Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times

Jul 24, 2025
pulisher
Jul 24, 2025

Pharvaris Secures Massive $201M Public Offering: HAE Drug Developer Sees Strong Investor Demand - Stock Titan

Jul 24, 2025
pulisher
Jul 23, 2025

Is Pharvaris N.V. a good long term investmentRapid growth opportunities - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Pharvaris: Deucrictibant Advanced To Target Two Sets Of HAE Patient Populations (PHVS) - Seeking Alpha

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Pharvaris N.V. stock priceHigh-yield capital appreciation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Pharvaris shares slide following $175 million equity offering - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Pharvaris stock drops after pricing $175 million public offering By Investing.com - Investing.com Canada

Jul 23, 2025
pulisher
Jul 23, 2025

Pharvaris stock drops after pricing $175 million public offering - Investing.com Australia

Jul 23, 2025
pulisher
Jul 23, 2025

Pharvaris' $175M Equity Raise: A Strategic Catalyst for HAE Market Leadership - AInvest

Jul 23, 2025
pulisher
Jul 22, 2025

Pharvaris' $175M Equity Raise: Fueling a Strategic Leap in the HAE Market - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Pharvaris prices $175 million public offering to fund angioedema programs By Investing.com - Investing.com India

Jul 22, 2025
pulisher
Jul 22, 2025

Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - The Manila Times

Jul 22, 2025
pulisher
Jul 22, 2025

Pharvaris prices $175 million public offering to fund angioedema programs - Investing.com

Jul 22, 2025
pulisher
Jul 22, 2025

Pharvaris Secures Massive $175M Public Offering to Advance Oral HAE Treatment Pipeline - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - GlobeNewswire Inc.

Jul 22, 2025
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
大文字化:     |  ボリューム (24 時間):